Article 1
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
Commission Implementing Regulation (EU) 2016/2045 of 23 November 2016 amending Regulation (EU) No 37/2010 as regards the substance gamithromycin (Text with EEA relevance )
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘gamithromycin’ is replaced by the following: Pharmacologically active Substance Marker residue Animal Species MRLs Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification ‘Gamithromycin Gamithromycin All ruminants except bovine 50 μg/kg Muscle Not for use in animals producing milk for human consumption Anti-infectious agents/Antibiotics’ 50 μg/kg Fat 300 μg/kg Liver 200 μg/kg Kidney Bovine 20 μg/kg Fat 200 μg/kg Liver 100 μg/kg Kidney Porcine 100 μg/kg Muscle NO ENTRY 100 μg/kg Skin and fat in natural proportions 100 μg/kg Liver 300 μg/kg Kidney
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.